Abstracts - faqs.org

Abstracts

Business, international

Search abstracts:
Abstracts » Business, international

Bear Stearns net rose 52% in period

Article Abstract:

Bear Stearns Cos. posted a rise of 52% in its net profits for the fiscal first quarter ending February 28, 2003. The company posted $274.3 million (258 million euros) in net profits for the period.

Author: Munk, Cheryl Winokur
Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Morgan Stanley, Bear Stearns post lower net profit

Article Abstract:

Bear Stearns Companies posted a drop of 18% in its net for the fiscal second quarter ending May 31, 2003. Morgan Stanley posted a 25% fall in net income for the same period.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
Morgan Stanley Group Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Instinet posts a quarterly loss as revenue declines by 23%

Article Abstract:

Instinet Group Inc. posted a loss of $112.2 million (104.4 million euros) for the 2002 fourth quarter. The group also posted a 23% drop in revenues to $267.1 million.

Publisher: Dow Jones Publishing Co. (Europe)
Publication Name: Wall Street Journal. Europe
Subject: Business, international
ISSN: 0921-9986
Year: 2003
Instinet Group Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Finance, Securities industry, Company sales and earnings, Company earnings/profit, Bear Stearns Companies Inc., BSC
Similar abstracts:
  • Abstracts: Philips net income fell 28% in quarter. Aegon's quarterly profit slid 36%. Philips posts big loss on investment charges
  • Abstracts: OTE profit declines. Telkom Indonesia posts higher net as revenue rises. Operating profit rises at Tele2
  • Abstracts: FDA approves generic versions of Merck's Zocor. Novartis to sell Prilosec copy in U.S. Abbott suspends late-stage trial of cancer drug
  • Abstracts: Global deals market is being transformed by 'strategic' buyers. Newbridge's bid for Chinese bank hits some snags
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.